Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Announcement under Regulation 30 (LODR)-Dividend Updates

 In terms of Regulation 30 read with Part A Schedule III of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015, we wish to inform you that the Board of Directors of the Company at its meeting held onMay 24, 2023has transacted the following business: 1) Approved audited standalone results for the quarter and period ended March 31st, 2023; 2) Recommended the payment of 0.50 per equity share as Final Dividend for the financial year 2022-23 subject to approval of shareholders in the Annual General Meeting.
24-05-2023
Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Board Meeting Outcome for Outcome Of Board Meeting

 In terms of Regulation 30 read with Part A Schedule III of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015, we wish to inform you that the Board of Directors of the Company at its meeting held on May 24, 2023 has transacted the following business: 1) Approved audited standalone results for the quarter and period ended March 31st, 2023; 2) Recommended the payment of 0.50 per equity share as Final Dividend for the financial year 2022-23 subject to approval of shareholders in the Annual General Meeting.
24-05-2023
Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Update on board meeting

 Lotus Eye Hospital And Institute Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2023 ,inter alia, to consider and approve Pursuant to our earlier intimation dated May 16 2023 regarding intimation of Board meeting on Wednesday, May 24,2023. We would like to further inform the Exchange that we shall inter-alia consider the following in addition to Audited Standalone Financial Results of the company for the quarter and year ended March 31, 2023 1. Consideration and proposed recommendation of Final dividend. As per our earlier intimation the trading window shall re-open from May 30 2023
17-05-2023
Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Board Meeting Intimation for For The Quarter Ending 31St March 2023

 Lotus Eye Hospital And Institute Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2023 ,inter alia, to consider and approve Pursuant to Regulation 29 and other applicable provisions of the SEBI (LODR) Regulations 2015, we wish to inform you that the Board of Directors of the company will be meeting on Wednesday, May 24,2023 inter-alia to consider the following: 1. Audited Standalone Financial Results of the company for the quarter and year ended March 31, 2023. Further, with reference to our earlier intimation March 30, 2023, we wish to inform that, in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Code of Conduct for Insiders of the Company, the trading window will re-open from May 30, 2023 onwards. Request you to kindly take the same on your record
16-05-2023
Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Clarification On Price Movement Of Scrip Of Lotus Eye Hospital And Institute Limited (Scrip Code 532998

 We hereby declare that all information which are price sensitive in nature has been disseminated to the respective stock exchanges within the stipulated time as per Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) 2015. Lotus Eye Hospital and Institute Limited has always maintained the sanctity of all unpublished price sensitive information and has adhered to corporate governance practices in true letter and spirit. We further declare that there are no pending announcements that need to be made public by Lotus Eye Hospital and Institute Limited as on date.
11-05-2023
Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Clarification sought from Lotus Eye Hospital And Institute Ltd

 The Exchange has sought clarification from Lotus Eye Hospital And Institute Ltd on May 10, 2023 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.
11-05-2023
Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Certificate Issued By A Practicing Company Secretary Under Regulation 40(9) Of SEBI (LODR) Regulations, 2015

 We are enclosing herewith certificate issued by a practicing Company Secretary under Regulation 40(9) of SEBI (LODR) Regulations, 2015.
27-04-2023
Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2

 Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company Lotus Eye Hospital And Institute Ltd 2 CIN NO. L85110TZ1997PLC007783 3 Report filed for FY 2022-2023 Details of the Current block (all figures in Rs crore): 4 2 - year block period (Specify financial years)* 2021-22 2022-23 5 Incremental borrowing done in FY (T)(a) 0.00 6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00 7 Actual borrowing done through debt securities in FY (T)(c) 0.00 8 Shortfall in the borrowing through debt securities, if any, for FY (T - 1) carried forward to FY (T) (d) 0 8Quantum of (d), which has been met from (c)(e)* 0 9 Shortfall, if any, in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative, write 'nil'}* 0 Details of penalty to be paid, if any, in respect to previous block (all figures in Rs crore): 2 - year Block period (Specify financial years)2021-22 2022-23 Amount of fine to be paid for the block, if applicable Fine = 0.2% of {(d) - (e)}#0.00 Name of the Company Secretary :-M Achuth MenonDesignation :-Company Secretary and Compliance Officer Name of the Chief Financial Officer :- Ramanujam Reghunathan Designation : -Chief Financial Officer Date: 26/04/2023
26-04-2023
Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

 Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyLotus Eye Hospital And Institute Ltd 2CIN NO.L85110TZ1997PLC007783 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. YES Name of the Company Secretary: M Achuth Menon Designation: Company Secretary and Compliance officer EmailId: [email protected] Name of the Chief Financial Officer: Ramanujam Reghunathan Designation: Chief Financial Officer EmailId: [email protected] Date: 26/04/2023 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
26-04-2023
Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Reconciliation Of Share Capital Audit For The Quarter Ended 31.03.2023 As Per Regulation 76 Of The SEBI (DP) Regulation,2018

 We are enclosing herewith the Reconciliation of Share Capital Audit Report for the quarter ended 31st March 2023 as per Regulation 76 of the SEBI (Depositories and Participants) Regulation 2018 and in terms of Circular No. CIR/MRD/DP/30/2010 dated 06.09.2010 issued by SEBI.
26-04-2023
Next Page
Close

Let's Open Free Demat Account